Mission Statement, Vision, & Core Values (2026) of Beijing Wandong Medical Technology Co., Ltd.

Founded in 1955, Beijing Wandong Medical Technology Co., Ltd. (600055.SS) has grown into a global force in medical imaging-exporting to over 100 countries and holding the domestic DR sales lead for more than ten consecutive years-backed by R&D and manufacturing bases in Beijing and Suzhou, an annual production capacity exceeding 6,000 units, and a team of over 500 R&D professionals that drives the launch of more than 10 new products each year; financially robust with a 12% net profit margin in 2023 (versus an industry average of 8%), the company reinvests aggressively in innovation-allocating ~14% of revenue to R&D-and pairs that technical commitment with operational strengths shown by a 0.5% product defect rate (well below the 1.5% industry average), a 92% customer satisfaction score in 2023, strategic hospital partnerships generating about ¥800 million in annual contracts, and a sustainability roadmap to cut its 50,000-ton carbon footprint by 30% by 2025 while pledging "lifelong caring" through high-performance, cost-effective imaging solutions.

Beijing Wandong Medical Technology Co., Ltd. (600055.SS) - Intro

• Domestic DR sales leader for more than ten consecutive years.
• Annual production capacity: over 6,000 units.
• R&D workforce: over 500 professionals with partnerships across top universities and research institutions.

• Deliver reliable, high-quality imaging solutions that improve diagnostic accuracy and patient outcomes.
• Enable accessible medical imaging across hospitals and clinics domestically and internationally.

• Be recognized globally as a top-tier medical imaging technology provider that combines innovation, affordability, and clinical excellence.
• Expand technological leadership through sustained R&D investment and strategic collaborations.

• Patient-centered design: prioritize safety, image quality, and usability.
• Innovation: continuous development driven by a 500+ strong R&D organization and academic partnerships.
• Quality and reliability: manufacturing standards supporting >6,000 units annual capacity and long product lifecycles.
• Global responsibility: ethical export practices and commitment to improving healthcare access in 100+ countries.

• R&D investment: maintain and grow the 500+ R&D team to accelerate product upgrades and new modalities.
• Manufacturing scalability: leverage Beijing and Suzhou bases to sustain >6,000 unit annual output and shorten lead times.
• Market leadership: consolidate domestic DR leadership while expanding share in global MRI/CT/ultrasound markets.
• Partnerships: deepen ties with universities and research centers for translational innovation and clinical validation.

Beijing Wandong Medical Technology Co., Ltd. (600055.SS) - Overview

• Mission focus: Deliver affordable, high-performance medical imaging products worldwide while collaborating closely with physicians to improve patient outcomes.
• Global orientation: Expand international partnerships and export channels to integrate best-practice imaging technology and service models.
• Community and continuity: Prioritize long-term customer relationships, after-sales service networks, and city-level healthcare support initiatives.

• Integrating global resources: Establish strategic alliances with overseas imaging research centers and component suppliers to cut unit BOM costs by targeted 8-12% over three years.
• High-quality development: Maintain annual R&D spend at 12-16% of revenue to accelerate AI-assisted imaging and low-dose CT technologies.
• High-performance operations: Improve manufacturing yield and after-sales response time, targeting a mean time to repair (MTTR) reduction of 20% within 24 months.
• Value-driven products: Expand mid- and entry-level product lines to increase cost-performance offerings and drive revenue from tier-2/3 hospitals and emerging markets.
• Doctor collaboration: Scale clinician co-development programs-joint trials, training, and feedback loops-to shorten clinical validation cycles and support adoption.

• "Lifelong caring" operationalized via extended warranty and modular upgrade programs covering >60% of active installed base.
• "Integrating with the world" evidenced by overseas distributor expansion supporting 35% export share and international clinical validations.
• "High cost performance" reflected in mid-market product pricing that captures demand from tier-2/3 hospitals while preserving margin through component optimization.

Beijing Wandong Medical Technology Co., Ltd. (600055.SS) - Mission Statement

• Patient-first orientation: lifelong caring and heartwarming service to city residents.
• Quality leadership: become a preeminent quality service provider in China through certified processes and measurable outcomes.
• Inclusion & diversity: recruit and retain diverse talent to drive innovation and empathy in care delivery.
• Relentless excellence: continuous improvement in clinical outcomes, product quality, and service delivery.
• Mutual benefit & common progress: cultivate partnerships across hospitals, research institutes, and suppliers for shared growth.
• Value creation with concerted efforts: teamwork-driven initiatives to optimize resource use and scale impact.

• Clinical quality metrics: reduce device-related adverse events and improve patient satisfaction scores through standardized protocols.
• R&D and innovation: increase investment in product development, digital healthcare, and post-market surveillance.
• Market expansion: deepen presence in tier-1 and tier-2 Chinese cities while supporting provincial healthcare modernization.
• Operational excellence: implement Lean and ISO-based quality systems across manufacturing and service units.

• Culture and governance: performance reviews incorporate diversity metrics, training hours per employee, and cross-functional project participation.
• Community engagement: annual public health campaigns, free screening events, and local partnerships aiming to reach >200,000 beneficiaries annually by 2024.
• Partnerships: co-development agreements with tier-1 hospitals and research centers to accelerate clinical validation and adoption.

Beijing Wandong Medical Technology Co., Ltd. (600055.SS) Vision Statement

Mission

Core Values

• Innovation: Prioritize breakthrough R&D to accelerate clinical value and product differentiation.
• Integrity: Maintain transparent, ethical business practices and a robust compliance framework.
• Customer Focus: Design products and services around clinician and patient needs.
• Collaboration: Build strategic partnerships with top-tier hospitals and research institutions.
• Quality: Ensure superior product reliability through rigorous controls.
• Sustainability: Commit to measurable reductions in environmental impact.

How Core Values Translate into Action (2023 Highlights)

• R&D Investment: Approximately 14% of total revenue allocated to R&D in 2023, supporting the launch of over 10 new products annually.
• Compliance & Integrity: Rolled out a comprehensive compliance program in 2023 including company-wide ethics training and a whistleblower system.
• Customer Satisfaction: Achieved a 92% customer satisfaction rating in 2023, up from 88% in 2022.
• Strategic Partnerships: Collaboration with leading hospitals such as Peking Union Medical College Hospital and the Chinese PLA General Hospital, producing an annual contract volume of ~¥800 million.
• Product Quality: Maintained a product defect rate of 0.5% in 2023 versus an industry average of 1.5%.
• Environmental Goals: Reported carbon footprint of 50,000 tons in 2023 with a target to reduce emissions by 30% by 2025 through energy-efficiency initiatives.

Key Performance Metrics

Operational Initiatives Supporting the Vision

• R&D acceleration: Cross-disciplinary teams and increased prototyping capacity to sustain >10 product launches per year.
• Quality assurance: Enhanced end-to-end QC processes and supplier audits to maintain defect rates well below industry norms.
• Customer engagement: Structured feedback loops and post-market surveillance to drive a rising customer satisfaction trend.
• Hospital partnerships: Joint clinical programs with top hospitals to validate products and secure recurring contract revenue (~¥800M annually).
• Sustainability roadmap: Investment in energy-efficient manufacturing, facility upgrades, and supply-chain decarbonization to meet the 30% emissions reduction goal by 2025.
• Compliance culture: Company-wide ethics training, whistleblower protections, and periodic audits launched in 2023.